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recurrent thrombotic 
events after Catastrophic 
Antiphopholipid Syndrome
To the Editor,
A 40-year-old man was transferred to our hospital in 
March 1994 for gross hematuria and decreased urine 
output. The patient exhibited chest pain and shortness 
of breath 2 weeks prior to the initial visit. These symp-
toms were relieved without particular management. 
Fever and chills developed thereafter followed by ab-
dominal pain. The patient visited a local clinic and was 
managed for acute pancreatitis and gastritis for 1 week. 
However, his symptoms did not subside and urine out-
put decreased progressively. 
On admission, he complained of severe headache, 
nausea, and both flank and back pain. Initial hemoglo-
bin levels and platelet counts were 16.9 g/dL and 478 × 
10
9/L, respectively. In the course of 3 days, anemia and 
thrombocytopenia rapidly developed, with a hemoglo-
bin level of 12.0 g/dL and a platelet count of 29 × 10
9/
L. Peripheral blood smear showed schistocytes suggest-
ing hemolytic anemia. Initial blood urea nitrogen and 
creatinine levels were 69 and 6.0 mg/dL, respectively. 
Magnetic resonance imaging of the kidney revealed 
acute cortical necrosis. He also had blood tinged spu-
tum, and the lung perfusion scan revealed perfusion 
defects in the right lower lobe, suggesting pulmonary 
embolism. Despite fluid therapy and the administration 
of diuretics, azotemia progressed rapidly over a 3-day 
period and he consequently underwent hemodialysis. 
Azotemia improved with increased urine output only 
after hemodialysis (Fig. 1).
The serologic results showed the presence of lupus an-
ticoagulant and IgM anticardiolipin antibody, and the 
patient was diagnosed with antiphospholipid syndrome 
(APS) with multiorgan failure. Retrospectively, his 
clinical presentation fits into the category of probable 
catastrophic APS (CAPS). However, neither intravenous 
heparin nor warfarin was used due to hemoptysis. 
Thereafter, he was admitted several times for coro-
nary events and pulmonary infarction. Two months af-
ter the first attack, he was readmitted due to chest pain. 
The echocardiogram showed inferior and septal myo-
cardial infarction and he was discharged with aspirin 
and clopidogrel. Three months later, he was readmitted 
due to chest pain, and a coronary angiogram showed 
right coronary artery focal stenosis (Fig. 2). He was lost 
to follow-up for 3 years and was readmitted to the hos-
pital in 1997 for pleuritic chest pain. Chest computed 
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Figure 1. Azotemia progressed rapidly with fluid and diuretics 
therapy. Urine output increased only after hemodialysis. HD, 
hemodialysis; Cr, creatinine.
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tomography scans revealed both lower lobe pulmonary 
infarctions. He was lost again to follow-up without anti-
thrombotic agents.
Recently, he was admitted for facial cellulitis associ-
ated with a burn, and the involved skin showed mul-
tiple ulcerations and necrosis (Fig. 3). His facial lesions 
improved with antibiotics. We started antithrombotic 
treatment for long-term prevention of recurrent throm-
botic events. 
CAPS is a life-threatening medical situation with a 
high mortality rate, although it represents in less than 
1% of patients with APS [1]. Therefore, clinical suspi-
cion and early diagnosis are important for improving 
survival from CAPS. Asherson et al. [1] and Erkan [2] 
noted that the recurrence of CAPS was not common, al-
though patients had been on continuous anticoagulation 
therapy. Among 73 CAPS survivors, 14 patients (19%) 
had further APS-related manifestations but no patient 
developed recurrent CAPS episodes during a follow-up 
of median 67.2 months [3]. Our case presents recurrent 
APS-related events after an initial CAPS episode.
No standardized treatment guideline for CAPS has 
been established due to the rarity of the disease and the 
lack of controlled studies [2]. Current treatment recom-
mendations are based on case series. Previous studies 
emphasized the importance of early anticoagulation, 
steroid, and plasma exchange during CAPS episodes 
[1,4,5]. Bucciarelli et al. [4] demonstrated that the mor-
tality rate decreased from 53% to 33% with a combina-
tion therapy of anticoagulation, steroids, and plasma 
exchange and/or intravenous immunoglobulins in 250 
patients in the CAPS registry. The reported patient 
could not maintain anticoagulation therapy because 
he had a bleeding episode at the initial admission and 
did not regularly visit clinics. The recurrent thrombotic 
events may have been due to the lack of anticoagulation 
therapy. This case suggests that continuous antico-
agulation is important for the prevention of recurrent 
thrombotic events after CAPS.
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Figure 2. Coronary angiogram showed right coronary artery 
50% focal stenosis, suggesting embolic infarct rather than 
atherosclerosis.
Figure 3. The patient developed facial cellulitis with 
multiple necrotic ulcerations after burn, suggesting possible 
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